INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF MYOCILIN (MYOC), COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, Nov. 5 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/026321) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF MYOCILIN (MYOC), COMPOSITIONS THEREOF, AND METHODS OF USE" on Apr 25, 2025. With publication no. WO/2025/227005, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Xiaokai (8236 Waverly LaneSan Diego, California 92129), EBLIMIT, Aiden (1812 Tammy StreetSan Diego, California 92021), LI, Puhui (10692 Passerine WaySan D...